The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Medical Probiotics-Global Market Insights and Sales Trends 2024

Medical Probiotics-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1844864

No of Pages : 113

Ask Your Query
Synopsis
Medical probiotics are live micro-organisms which, when administrated in adequate amounts, confer a health benefit on the host. While the traditional delivery vehicle for probiotics was fresh dairy products, they are now found in many varieties of dietary supplements and healthcare products.
The global Medical Probiotics market size is expected to reach US$ 92 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Medical Probiotics in various end use industries. The expanding demands from the Pharmaceuticals, Dietary Supplements and Others,, are propelling Medical Probiotics market. Bifidobacterium, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Lactobacillus segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Medical Probiotics market, driven by demand from China, the second largest economy with some signs of stabilising, the Medical Probiotics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Medical Probiotics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Medical Probiotics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Medical Probiotics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Medical Probiotics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Medical Probiotics covered in this report include DowDuPont, Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Novozymes, etc.
The global Medical Probiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
DowDuPont
Chr. Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Novozymes
DSM
Ganeden
Glory Biotech
Unique Biotech
Winclove Probiotics
UAS Laboratories
Synbiotech
Global Medical Probiotics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medical Probiotics market, Segment by Type:
Bifidobacterium
Lactobacillus
Others
Global Medical Probiotics market, by Application
Pharmaceuticals
Dietary Supplements
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Medical Probiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Medical Probiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Medical Probiotics Market Overview
1.1 Medical Probiotics Product Overview
1.2 Medical Probiotics Market Segment by Type
1.2.1 Bifidobacterium
1.2.2 Lactobacillus
1.2.3 Others
1.3 Global Medical Probiotics Market Size by Type
1.3.1 Global Medical Probiotics Market Size Overview by Type (2018-2029)
1.3.2 Global Medical Probiotics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Medical Probiotics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Medical Probiotics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Medical Probiotics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Medical Probiotics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Medical Probiotics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Medical Probiotics Sales Breakdown by Type (2018-2023)
2 Global Medical Probiotics Market Competition by Company
2.1 Global Top Players by Medical Probiotics Sales (2018-2023)
2.2 Global Top Players by Medical Probiotics Revenue (2018-2023)
2.3 Global Top Players by Medical Probiotics Price (2018-2023)
2.4 Global Top Manufacturers Medical Probiotics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Medical Probiotics Market Competitive Situation and Trends
2.5.1 Medical Probiotics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Medical Probiotics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medical Probiotics as of 2022)
2.7 Date of Key Manufacturers Enter into Medical Probiotics Market
2.8 Key Manufacturers Medical Probiotics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Medical Probiotics Status and Outlook by Region
3.1 Global Medical Probiotics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Medical Probiotics Historic Market Size by Region
3.2.1 Global Medical Probiotics Sales in Volume by Region (2018-2023)
3.2.2 Global Medical Probiotics Sales in Value by Region (2018-2023)
3.2.3 Global Medical Probiotics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Medical Probiotics Forecasted Market Size by Region
3.3.1 Global Medical Probiotics Sales in Volume by Region (2024-2029)
3.3.2 Global Medical Probiotics Sales in Value by Region (2024-2029)
3.3.3 Global Medical Probiotics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Medical Probiotics by Application
4.1 Medical Probiotics Market Segment by Application
4.1.1 Pharmaceuticals
4.1.2 Dietary Supplements
4.1.3 Others
4.2 Global Medical Probiotics Market Size by Application
4.2.1 Global Medical Probiotics Market Size Overview by Application (2018-2029)
4.2.2 Global Medical Probiotics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Medical Probiotics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Medical Probiotics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Medical Probiotics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Medical Probiotics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Medical Probiotics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Medical Probiotics Sales Breakdown by Application (2018-2023)
5 North America Medical Probiotics by Country
5.1 North America Medical Probiotics Historic Market Size by Country
5.1.1 North America Medical Probiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Medical Probiotics Sales in Volume by Country (2018-2023)
5.1.3 North America Medical Probiotics Sales in Value by Country (2018-2023)
5.2 North America Medical Probiotics Forecasted Market Size by Country
5.2.1 North America Medical Probiotics Sales in Volume by Country (2024-2029)
5.2.2 North America Medical Probiotics Sales in Value by Country (2024-2029)
6 Europe Medical Probiotics by Country
6.1 Europe Medical Probiotics Historic Market Size by Country
6.1.1 Europe Medical Probiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Medical Probiotics Sales in Volume by Country (2018-2023)
6.1.3 Europe Medical Probiotics Sales in Value by Country (2018-2023)
6.2 Europe Medical Probiotics Forecasted Market Size by Country
6.2.1 Europe Medical Probiotics Sales in Volume by Country (2024-2029)
6.2.2 Europe Medical Probiotics Sales in Value by Country (2024-2029)
7 Asia-Pacific Medical Probiotics by Region
7.1 Asia-Pacific Medical Probiotics Historic Market Size by Region
7.1.1 Asia-Pacific Medical Probiotics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Medical Probiotics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Medical Probiotics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Medical Probiotics Forecasted Market Size by Region
7.2.1 Asia-Pacific Medical Probiotics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Medical Probiotics Sales in Value by Region (2024-2029)
8 Latin America Medical Probiotics by Country
8.1 Latin America Medical Probiotics Historic Market Size by Country
8.1.1 Latin America Medical Probiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Medical Probiotics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Medical Probiotics Sales in Value by Country (2018-2023)
8.2 Latin America Medical Probiotics Forecasted Market Size by Country
8.2.1 Latin America Medical Probiotics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Medical Probiotics Sales in Value by Country (2024-2029)
9 Middle East and Africa Medical Probiotics by Country
9.1 Middle East and Africa Medical Probiotics Historic Market Size by Country
9.1.1 Middle East and Africa Medical Probiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Medical Probiotics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Medical Probiotics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Medical Probiotics Forecasted Market Size by Country
9.2.1 Middle East and Africa Medical Probiotics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Medical Probiotics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 DowDuPont
10.1.1 DowDuPont Company Information
10.1.2 DowDuPont Introduction and Business Overview
10.1.3 DowDuPont Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 DowDuPont Medical Probiotics Products Offered
10.1.5 DowDuPont Recent Development
10.2 Chr. Hansen
10.2.1 Chr. Hansen Company Information
10.2.2 Chr. Hansen Introduction and Business Overview
10.2.3 Chr. Hansen Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Chr. Hansen Medical Probiotics Products Offered
10.2.5 Chr. Hansen Recent Development
10.3 Lallemand
10.3.1 Lallemand Company Information
10.3.2 Lallemand Introduction and Business Overview
10.3.3 Lallemand Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Lallemand Medical Probiotics Products Offered
10.3.5 Lallemand Recent Development
10.4 China-Biotics
10.4.1 China-Biotics Company Information
10.4.2 China-Biotics Introduction and Business Overview
10.4.3 China-Biotics Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 China-Biotics Medical Probiotics Products Offered
10.4.5 China-Biotics Recent Development
10.5 Nestle
10.5.1 Nestle Company Information
10.5.2 Nestle Introduction and Business Overview
10.5.3 Nestle Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Nestle Medical Probiotics Products Offered
10.5.5 Nestle Recent Development
10.6 Danone
10.6.1 Danone Company Information
10.6.2 Danone Introduction and Business Overview
10.6.3 Danone Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Danone Medical Probiotics Products Offered
10.6.5 Danone Recent Development
10.7 Probi
10.7.1 Probi Company Information
10.7.2 Probi Introduction and Business Overview
10.7.3 Probi Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Probi Medical Probiotics Products Offered
10.7.5 Probi Recent Development
10.8 BioGaia
10.8.1 BioGaia Company Information
10.8.2 BioGaia Introduction and Business Overview
10.8.3 BioGaia Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 BioGaia Medical Probiotics Products Offered
10.8.5 BioGaia Recent Development
10.9 Novozymes
10.9.1 Novozymes Company Information
10.9.2 Novozymes Introduction and Business Overview
10.9.3 Novozymes Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Novozymes Medical Probiotics Products Offered
10.9.5 Novozymes Recent Development
10.10 DSM
10.10.1 DSM Company Information
10.10.2 DSM Introduction and Business Overview
10.10.3 DSM Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 DSM Medical Probiotics Products Offered
10.10.5 DSM Recent Development
10.11 Ganeden
10.11.1 Ganeden Company Information
10.11.2 Ganeden Introduction and Business Overview
10.11.3 Ganeden Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Ganeden Medical Probiotics Products Offered
10.11.5 Ganeden Recent Development
10.12 Glory Biotech
10.12.1 Glory Biotech Company Information
10.12.2 Glory Biotech Introduction and Business Overview
10.12.3 Glory Biotech Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Glory Biotech Medical Probiotics Products Offered
10.12.5 Glory Biotech Recent Development
10.13 Unique Biotech
10.13.1 Unique Biotech Company Information
10.13.2 Unique Biotech Introduction and Business Overview
10.13.3 Unique Biotech Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Unique Biotech Medical Probiotics Products Offered
10.13.5 Unique Biotech Recent Development
10.14 Winclove Probiotics
10.14.1 Winclove Probiotics Company Information
10.14.2 Winclove Probiotics Introduction and Business Overview
10.14.3 Winclove Probiotics Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Winclove Probiotics Medical Probiotics Products Offered
10.14.5 Winclove Probiotics Recent Development
10.15 UAS Laboratories
10.15.1 UAS Laboratories Company Information
10.15.2 UAS Laboratories Introduction and Business Overview
10.15.3 UAS Laboratories Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.15.4 UAS Laboratories Medical Probiotics Products Offered
10.15.5 UAS Laboratories Recent Development
10.16 Synbiotech
10.16.1 Synbiotech Company Information
10.16.2 Synbiotech Introduction and Business Overview
10.16.3 Synbiotech Medical Probiotics Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Synbiotech Medical Probiotics Products Offered
10.16.5 Synbiotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Medical Probiotics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Medical Probiotics Industrial Chain Analysis
11.4 Medical Probiotics Market Dynamics
11.4.1 Medical Probiotics Industry Trends
11.4.2 Medical Probiotics Market Drivers
11.4.3 Medical Probiotics Market Challenges
11.4.4 Medical Probiotics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Medical Probiotics Distributors
12.3 Medical Probiotics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock